21Shares Files for Injective (INJ) ETF Launch

21Shares has applied for a new exchange-traded fund focused on Injective (INJ), according to ChainCatcher. The filing was shared on Injective’s official X account, confirming the company’s move into the DeFi ETF market. This application follows a trend of spot Bitcoin and Ethereum ETFs receiving approval in major markets, indicating growing interest from institutions in this sector. If approved, the INJ ETF would offer traditional investors regulated access to one of the most dynamic Layer-1 DeFi ecosystems within the crypto space.